Atsushi Shimazaki

760 total citations
31 papers, 602 citations indexed

About

Atsushi Shimazaki is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Atsushi Shimazaki has authored 31 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Ophthalmology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Molecular Biology. Recurrent topics in Atsushi Shimazaki's work include Glaucoma and retinal disorders (30 papers), Retinal Diseases and Treatments (13 papers) and Ocular Surface and Contact Lens (8 papers). Atsushi Shimazaki is often cited by papers focused on Glaucoma and retinal disorders (30 papers), Retinal Diseases and Treatments (13 papers) and Ocular Surface and Contact Lens (8 papers). Atsushi Shimazaki collaborates with scholars based in Japan and United States. Atsushi Shimazaki's co-authors include Hideaki Hara, Takeshi Matsugi, Takazumi Taniguchi, Naruhiro Ishida, Noriko Odani‐Kawabata, Masaaki Sasaoka, Yasutaka Takagi, Masamitsu Shimazawa, Tadashi Nakajima and B’Ann T. Gabelt and has published in prestigious journals such as PLoS ONE, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Atsushi Shimazaki

31 papers receiving 590 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Atsushi Shimazaki 474 200 166 160 71 31 602
Reiko Yamagishi 284 0.6× 223 1.1× 56 0.3× 75 0.5× 64 0.9× 30 499
K.–G. Schmidt 364 0.8× 185 0.9× 60 0.4× 172 1.1× 86 1.2× 28 540
C Severin 425 0.9× 268 1.3× 95 0.6× 80 0.5× 38 0.5× 26 627
S. Lerner 774 1.6× 388 1.9× 79 0.5× 229 1.4× 129 1.8× 21 946
Tomoyuki Isobe 242 0.5× 164 0.8× 34 0.2× 79 0.5× 53 0.7× 10 389
Mojdeh Abbasi 186 0.4× 249 1.2× 23 0.1× 65 0.4× 45 0.6× 24 423
Brian C. Oveson 410 0.9× 456 2.3× 42 0.3× 186 1.2× 44 0.6× 14 700
Sonali Nashine 230 0.5× 293 1.5× 17 0.1× 59 0.4× 72 1.0× 21 498
Jonathan Li 156 0.3× 221 1.1× 15 0.1× 47 0.3× 39 0.5× 15 400
Manabu Hirasawa 256 0.5× 246 1.2× 18 0.1× 77 0.5× 52 0.7× 17 453

Countries citing papers authored by Atsushi Shimazaki

Since Specialization
Citations

This map shows the geographic impact of Atsushi Shimazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Shimazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Shimazaki more than expected).

Fields of papers citing papers by Atsushi Shimazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Shimazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Shimazaki. The network helps show where Atsushi Shimazaki may publish in the future.

Co-authorship network of co-authors of Atsushi Shimazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Shimazaki. A scholar is included among the top collaborators of Atsushi Shimazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Shimazaki. Atsushi Shimazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuwa, Masahiro, et al.. (2023). Downregulation of COL12A1 and COL13A1 by a selective EP2 receptor agonist, omidenepag, in human trabecular meshwork cells. PLoS ONE. 18(1). e0280331–e0280331. 4 indexed citations
2.
Fuwa, Masahiro, Atsushi Shimazaki, Noriko Odani‐Kawabata, et al.. (2021). Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys. Journal of Ocular Pharmacology and Therapeutics. 37(4). 223–229. 16 indexed citations
3.
Yamamoto, Kotaro T., Taiki Kokubun, Kota Sato, et al.. (2019). The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery. Scientific Reports. 9(1). 19288–19288. 8 indexed citations
4.
Fuwa, Masahiro, et al.. (2019). Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol. Scientific Reports. 9(1). 7491–7491. 3 indexed citations
5.
Kokubun, Taiki, Kotaro T. Yamamoto, Kota Sato, et al.. (2019). The effectiveness of colchicine combined with mitomycin C to prolong bleb function in trabeculectomy in rabbits. PLoS ONE. 14(3). e0213811–e0213811. 3 indexed citations
6.
Taniguchi, Takazumi, Miki Takahashi, Ryo Iwamura, et al.. (2017). Omidenepag isopropyl, a selective EP2 agonist, shows additive intraocular pressure (IOP)-lowering effects when used concomitantly with existing anti-glaucoma drugs in animal models. Investigative Ophthalmology & Visual Science. 58(8). 2105–2105. 1 indexed citations
7.
Fuwa, Masahiro, et al.. (2016). Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination. PLoS ONE. 11(7). e0158797–e0158797. 8 indexed citations
8.
Shimazaki, Atsushi, et al.. (2016). Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study. The Open Ophthalmology Journal. 10(1). 146–153. 9 indexed citations
9.
Iwamura, Ryo, et al.. (2015). DE-117, a selective EP2 agonist, lowered intraocular pressure in animal models. Investigative Ophthalmology & Visual Science. 56(7). 5709–5709. 6 indexed citations
10.
Shimazaki, Atsushi, et al.. (2015). Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models. Journal of Ocular Pharmacology and Therapeutics. 31(9). 518–524. 3 indexed citations
11.
Shimazaki, Atsushi, et al.. (2013). Ocular hypotensive efficacy of Src-family tyrosine kinase inhibitors via different cellular actions from Rock inhibitors. Experimental Eye Research. 119. 97–105. 7 indexed citations
12.
Chi, Zai‐Long, Masakazu Akahori, Minoru Obazawa, et al.. (2010). Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Human Molecular Genetics. 19(13). 2606–2615. 118 indexed citations
13.
Arnold, John J., Yash A. Choksi, Xin Chen, et al.. (2009). Eyedrops Containing SA9000 Prodrugs Result in Sustained Reductions in Intraocular Pressure in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 25(3). 179–186. 6 indexed citations
14.
Sasaoka, Masaaki, Takazumi Taniguchi, Masamitsu Shimazawa, et al.. (2006). Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits. Experimental Eye Research. 83(3). 629–637. 39 indexed citations
15.
Ishida, Naruhiro, Noriko Odani‐Kawabata, Atsushi Shimazaki, & Hideaki Hara. (2006). Prostanoids in the Therapy of Glaucoma. Cardiovascular Drug Reviews. 24(1). 1–10. 38 indexed citations
16.
Shimazaki, Atsushi. (2006). . Folia Pharmacologica Japonica. 128(4). 250–254. 1 indexed citations
17.
Taniguchi, Takazumi, Masamitsu Shimazawa, Masaaki Sasaoka, Atsushi Shimazaki, & Hideaki Hara. (2006). Endothelin-1 Impairs Retrograde Axonal Transport and Leads to Axonal Injury in Rat Optic Nerve. Current Neurovascular Research. 3(2). 81–88. 40 indexed citations
18.
Ishida, Naruhiro, et al.. (2005). Continuous Monitoring of Circadian Variations in Intraocular Pressure by Telemetry System Throughout a 12-Week Treatment with Timolol Maleate in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 21(6). 436–444. 21 indexed citations
19.
Takagi, Yasutaka, Tadashi Nakajima, Atsushi Shimazaki, et al.. (2004). Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Experimental Eye Research. 78(4). 767–776. 125 indexed citations
20.
Takagi, Yasutaka, Takeshi Matsugi, Masaaki Kageyama, et al.. (2003). Potent Intraocular Pressure Reducing Effects of AFP-168, a New Prostanoid FP Receptor Agonist. Investigative Ophthalmology & Visual Science. 44(13). 4407–4407. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reiko Yamagishi Breakdown of academic impact, for papers by K.–G. Schmidt Breakdown of academic impact, for papers by C Severin Breakdown of academic impact, for papers by S. Lerner Breakdown of academic impact, for papers by Tomoyuki Isobe Breakdown of academic impact, for papers by Mojdeh Abbasi Breakdown of academic impact, for papers by Brian C. Oveson Breakdown of academic impact, for papers by Sonali Nashine Breakdown of academic impact, for papers by Jonathan Li Breakdown of academic impact, for papers by Manabu Hirasawa
Rankless by CCL
2026